FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer Read more →

The future of RAS inhibitors Read more →

Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'? Read more →